Hematología y Hemoterapia

Resultados: 405
Tipo Título / Nombre Autor(es) Año
Lack of prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative, b-cell precursor all treated according to MRD oriented protocols Ribera JM, Morgades M, Ciudad J, Montesinos P, Tormo M, González Campos J, et al 2016
Preliminary results of the flugaza trial: a phase iii randomized, open label study comparing azacytidine versus fludarabine and cytarabine (fluga scheme) in elderly patients with newly diagnosed acute myeloid leukemia Vives S, Martínez-Sánchez MD, Bergua J, Algarra L, Herrera Pilar MD, Tormo M, et al 2016
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM Mateos MV, Martínez-López J, Hernández MT, Ocio EM, Rosiñol L, Martínez R, et al 2016
Minimal residual disease monitoring and immune profiling using second generation flow cytometry in elderly multiple myeloma Paiva B, Cedena MT, Puig N, Arana P, Vidriales MB, Cordon L, et al 2016
Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines Lozano ML, Revilla N, González-López TJ, Novelli S, González-Porras JR, Sánchez-Gonzalez B, et al 2016
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, et al 2016
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies? Sánchez-Correa B, Campos C, Pera A, Bergua JM, Arcos MJ, Bañas H, et al 2016
Seguridad Transfusional y efectos adversos: protocolos y actuaciones Ibáñez Espacio F, Lanzas Merino F 2015
Seguridad transfusional y efectos adversos Ibáñez Espacio F, Lanzas Merino 2015
Púrpura Trombótica Trombocitopénica Ibáñez Espacio F 2015